Sanofi exec says remote work takes away employee ‘serendipity’
© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use ...
Tag: pharmaceutical industry
Six years ago 23andMe was worth $6 billion. Now CEO Anne Wojcicki is trying to buy it back for $75 million
Experts say the CEO’s second attempt to buy back the troubled DNA startup comes with a slew of corporate governance ...
With RFK Jr. in the driver’s seat, nutraceutical and supplement makers see chance to cash in
Currently, the FDA can’t even require that supplements be effective before they are sold. Read More Source link
Weight-loss drug Zepbound helped drive Ireland to $76 billion in goods exports to the U.S. last year—a bittersweet reminder of the challenges ahead
Ireland's pharmaceutical industry shipped billions' worth of goods to the U.S., but face threats from Trump 2.0. Read More Source ...
Gen Z prefers more expensive brand-name meds to generic drugs, Tebra survey says
© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use ...
Personalized vaccine offers hope for patients with late-stage kidney cancer, clinical trial shows
Researchers, in a sense, manipulated each patient’s cancer in an attempt to prevent it from coming back. Read More Source ...
48% of Americans don’t know risks of daily, low-dose aspirin outweigh benefits, survey says
Nearly half of survey respondents (48%) incorrectly said that the benefits of taking low-dose aspirin daily to lower one’s odds ...
Novo Nordisk stock surges 7% after Ozempic maker’s latest weight loss drug shows promise
The new treatment targets gut hormone GLP-1 but also mimics amylin, a hormone released by the pancreas that suppresses hunger. ...
Nasal spray for depression now FDA-approved as standalone treatment
© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use ...
British pharma giant GSK to acquire U.S. drug developer IDRx in $1.15 billion deal
The biopharmaceutical company's drug in development is designed to treat gastrointestinal stromal tumors (GIST). Read More Source link
Welcome to LJ News Opinions, where breaking news stories have captivated us for over 20 years.
Join us in this journey of sharing points of view about the news – read, react, engage, and unleash your opinion!